Amphista Therapeutics is a fast-growing Cambridge-based biotech and the leading European Targeted Protein Degradation (TPD) company. Our unique scientific approach to TPD, one of the hottest areas in modern drug discovery, gives us a range of advantages over other therapeutic strategies. Initially founded from the laboratory of Professor Alessio Ciulli (University of Dundee) our team comprises both academic and drug discovery pioneers of the TPD field and a growing R&D team focused on advancing a portfolio of medicines to the clinic using our proprietary next generation TPD technologies.
We have completed an oversubscribed $53M funding round which was recently extended with investment by the Dementia Discovery fund. During 2022 we were delighted to announce in two separate collaboration deals with Bristol Myers Squibb and Merck Healthcare which will allow us to grow and advance our therapeutic portfolio even faster. This excellent progress has been recognised Amphista named as a Fierce Biotech, Fierce15 winner for 2022.
The Associate Director Biology will be responsible for managing a team of scientists to contribute to the successful delivery of multiple Amphista discovery projects. The successful candidate will be experienced in the area of oncology and will take advantage of the unique benefits of Amphista technology to develop novel medicines to addressing targets or pharmacology not achievable with conventional small molecules or standard TPD approaches.
The ideal candidate will be goal oriented, a creative problem solver, clear thinking with excellent communication skills and an ability to engage their own team and the broader R&D team around them.
In their role, they will also attend and represent Amphista at scientific and industry-led meetings.
Leadership and Management
MNCJobs.co.uk will not be responsible for any payment made to a third-party. All Terms of Use are applicable.